Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the ...
15hon MSN
Novo prepares for fiercer fight
Danish pharma giant Novo Nordisk's recent launch of Ozempic in India alongside a 37% price cut on Wegovy points out at more ...
The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.
Camilla Sylvest, der i foråret forlod Novo Nordisk efter 28 år i koncernen, hvor den sidste tid bød på et historisk kursfald, ...
Pop Mart, the Chinese firm behind the mischievously grinning, nine-toothed Labubu dolls that shoppers have queued up to buy ...
En 51-årig mand fra Nordmakedonien er idømt 4,5 års fængsel for frihedsberøvelse, grov vold, trusler og voldtægt mod en ...
Emil Kongshøj Larsen, Executive Vice President for International Operations at Novo Nordisk, talks to BT about India’s role ...
Eli Lilly ( LLY 1.19%) and Novo Nordisk ( NVO 2.44%) are two of the leading companies in the fast-growing GLP-1 weight loss ...
Den finske skønhedskonkurrence Miss Finland har besluttet at trække titlen tilbage fra den seneste vinder, Sarah Dzafce, ...
17don MSN
Why are fit guys microdosing GLP-1s?
Healthy people are injecting tiny doses of obesity medication to look and feel even better. But at what danger?
CHONGQING, CHINA - SEPTEMBER 10: In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. The maker of Wegovy and Ozempic, ...
Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn't slow the progress of Alzheimer's disease. Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback